An Oklahoma court case highlights the health care giant’s role in the epidemic as a leading supplier of opioid ingredients. Source: NYT > Business – Katie Thomas and Tiffany Hsu
$572 Million Decision Against Johnson & Johnson in Landmark Opioid Trial
The first case against a drug manufacturer for the national public health disaster may indicate what lies ahead in 2,000 more lawsuits. Source: NYT > Business – Jan Hoffman
Congo Draws Up a New Battle Plan Against Ebola Amid Power Struggle
Following the resignation of the country’s health minister, the president will take over the response and deploy a new vaccine. Source: NYT > Business – Donald G. McNeil Jr. and Denise Grady
McKinsey Advised Johnson & Johnson on Increasing Opioid Sales
In a trial in Oklahoma, records showed the firm was consulted about sales at a time when abuse of pain medicine was widespread. Cases in two other states also shed light on its role. Source: NYT > Business – Walt Bogdanich
Drug Companies Are Focusing on the Poor After Decades of Ignoring Them
The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world. Source: NYT > Business – Donald G. McNeil Jr.
Oklahoma Faces Off Against J & J in First Trial of an Opioid Maker
With Purdue Pharma and Teva settling the case, the state sought to hold J & J responsible for the broader opioid crisis. The company argued that it operated responsibly and lawfully. Source: NYT > Business – Jan Hoffman